News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
742,810 Results
Type
Article (43424)
Company Profile (276)
Press Release (699096)
Multimedia
Podcasts (98)
Webinars (20)
Section
Business (207108)
Career Advice (2065)
Deals (36027)
Drug Delivery (133)
Drug Development (81979)
Employer Resources (173)
FDA (16671)
Job Trends (15189)
News (350495)
Policy (33215)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2687)
Academic (1)
Accelerated approval (55)
ADA (44)
Adcomms (29)
Allergies (191)
Alliances (50397)
ALS (222)
Alzheimer's disease (1845)
Antibody-drug conjugate (ADC) (503)
Approvals (17112)
Artificial intelligence (722)
ASCO (329)
Autoimmune disease (333)
Automation (61)
Bankruptcy (366)
Best Places to Work (11705)
BIOSECURE Act (20)
Biosimilars (229)
Biotechnology (174)
Bladder cancer (202)
Brain cancer (75)
Breast cancer (792)
Cancer (6252)
Cardiovascular disease (504)
Career advice (1760)
Career pathing (45)
CAR-T (352)
CDC (58)
Celiac Disease (3)
Cell therapy (952)
Cervical cancer (55)
Clinical research (71620)
Collaboration (2198)
Commercialization (1)
Company closure (5)
Compensation (1484)
Complete response letters (83)
COVID-19 (2803)
CRISPR (115)
C-suite (1222)
Cystic fibrosis (156)
Data (8567)
Decentralized trials (3)
Denatured (30)
Depression (173)
Dermatology (94)
Diabetes (660)
Diagnostics (7206)
Digital health (63)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (356)
Drug pricing (201)
Drug shortages (31)
Duchenne muscular dystrophy (297)
Earnings (92661)
Editorial (67)
Employer branding (21)
Employer resources (152)
Events (121335)
Executive appointments (1123)
FDA (20613)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (35)
Funding (1842)
Gene editing (244)
Generative AI (61)
Gene therapy (745)
GLP-1 (1101)
Government (4796)
Grass and pollen (6)
Guidances (416)
Healthcare (19276)
Hematology (192)
HIV (90)
Huntington's disease (61)
IgA nephropathy (110)
Immunology and inflammation (299)
Immuno-oncology (101)
Indications (213)
Infectious disease (3174)
Inflammatory bowel disease (220)
Inflation Reduction Act (14)
Influenza (143)
Intellectual property (315)
Interviews (325)
IPO (16846)
IRA (50)
Job creations (3772)
Job search strategy (1459)
JPM (59)
Kidney cancer (20)
Labor market (110)
Layoffs (576)
Leadership (42)
Legal (8072)
Liver cancer (103)
Longevity (34)
Lung cancer (828)
Lymphoma (470)
Machine learning (63)
Management (59)
Manufacturing (1132)
Marketing (1)
MASH (208)
Medical affairs (1)
Medical device (14050)
Medtech (14211)
Mergers & acquisitions (20485)
Metabolic disorders (1635)
mRNA (230)
Multiple sclerosis (196)
NASH (18)
Neurodegenerative disease (453)
Neuropsychiatric disorders (109)
Neuroscience (3464)
Neurotech (1)
NextGen: Class of 2026 (6563)
Non-profit (4597)
Now hiring (81)
Obesity (751)
Opinion (297)
Ovarian cancer (237)
Pain (264)
Pancreatic cancer (347)
Parkinson's disease (389)
Partnered (36)
Patents (629)
Patient recruitment (737)
Peanut (67)
People (60498)
Pharmaceutical (59)
Pharmacy benefit managers (33)
Phase 1 (22348)
Phase 2 (31541)
Phase 3 (23465)
Pipeline (9676)
Policy (328)
Postmarket research (2590)
Preclinical (9589)
Press Release (67)
Prostate cancer (334)
Psychedelics (57)
Radiopharmaceuticals (343)
Rare diseases (1148)
Real estate (6186)
Recruiting (70)
Regulatory (26032)
Reports (56)
Research institute (2483)
Resumes & cover letters (355)
Rett syndrome (43)
RNA editing (24)
RSV (90)
Schizophrenia (183)
Series A (313)
Series B (227)
Service/supplier (11)
Sickle cell disease (118)
Special edition (24)
Spinal muscular atrophy (168)
Sponsored (51)
Startups (3693)
State (2)
Stomach cancer (18)
Supply chain (135)
Tariffs (87)
The Weekly (66)
Vaccines (1141)
Venture capital (118)
Weight loss (482)
Women's health (136)
Worklife (20)
Date
Today (69)
Last 7 days (428)
Last 30 days (2507)
Last 365 days (30539)
2026 (15628)
2025 (30317)
2024 (35415)
2023 (40334)
2022 (51425)
2021 (56019)
2020 (54498)
2019 (46970)
2018 (35337)
2017 (32517)
2016 (31990)
2015 (38040)
2014 (31915)
2013 (27002)
2012 (29127)
2011 (29785)
2010 (27830)
Location
Africa (759)
Alabama (93)
Alaska (7)
Arizona (368)
Arkansas (14)
Asia (40750)
Australia (6683)
California (13927)
Canada (3931)
China (1475)
Colorado (594)
Connecticut (608)
Delaware (433)
Europe (88464)
Florida (2093)
Georgia (444)
Hawaii (3)
Idaho (63)
Illinois (1138)
India (96)
Indiana (628)
Iowa (24)
Japan (589)
Kansas (134)
Kentucky (52)
Louisiana (58)
Maine (76)
Maryland (1660)
Massachusetts (9985)
Michigan (376)
Minnesota (755)
Mississippi (6)
Missouri (158)
Montana (36)
Nebraska (30)
Nevada (150)
New Hampshire (85)
New Jersey (3652)
New Mexico (31)
New York (3648)
North Carolina (1771)
North Dakota (9)
Northern California (7012)
Ohio (430)
Oklahoma (23)
Oregon (42)
Pennsylvania (2769)
Puerto Rico (31)
Rhode Island (52)
South America (1143)
South Carolina (87)
South Dakota (2)
Southern California (5525)
Tennessee (224)
Texas (2235)
United States (49177)
Utah (416)
Vermont (2)
Virginia (342)
Washington D.C. (81)
Washington State (1110)
West Virginia (4)
Wisconsin (133)
Wyoming (2)
742,810 Results for "underwriters laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option
June 5, 2026
·
4 min read
Press Releases
IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
June 11, 2026
·
3 min read
Press Releases
Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
June 12, 2026
·
3 min read
Press Releases
Jade Biosciences Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
June 7, 2026
·
4 min read
Press Releases
Diazyme Laboratories, Inc. Announces FDA 510(k) Clearance for Lipoprotein(a) Molarity Assay
June 19, 2026
·
1 min read
Press Releases
Spyre Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $463.5 Million
April 17, 2026
·
2 min read
Press Releases
Aura Biosciences Announces Closing of $299 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 6, 2026
·
3 min read
Press Releases
Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $403 Million
March 27, 2026
·
3 min read
Press Releases
Medline Inc. announces closing of secondary offering of Class A common stock and full exercise of underwriters’ option to purchase additional shares
March 10, 2026
·
5 min read
Press Releases
Nektar Therapeutics Announces Closing of $373.8 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
April 24, 2026
·
3 min read
1 of 74,281
Next
